Kukje Pharma Co., Ltd. (KRX:002720)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,875.00
-30.00 (-0.61%)
Mar 12, 2026, 12:30 PM KST

Kukje Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
99,878103,034119,890106,115112,861176,865
Market Cap Growth
0%-14.06%12.98%-5.98%-36.19%118.14%
Enterprise Value
112,243124,008140,751127,215143,804207,752
Last Close Price
4875.005028.705883.385205.695534.718670.79
PE Ratio
14.0019.80-29.83-80.28
PS Ratio
0.570.660.890.840.941.36
PB Ratio
1.051.151.411.431.652.51
P/TBV Ratio
1.061.161.431.451.672.54
P/FCF Ratio
10.60100.1447.4020.2314.65-
P/OCF Ratio
9.1226.1533.5316.3211.7634.68
EV/Sales Ratio
0.650.791.041.001.201.59
EV/EBITDA Ratio
9.4612.5263.5513.0352.4221.49
EV/EBIT Ratio
12.9518.50-24.13-34.39
EV/FCF Ratio
11.91120.5355.6524.2618.66-
Debt / Equity Ratio
0.320.330.360.390.530.54
Debt / EBITDA Ratio
2.572.9813.842.9313.123.94
Debt / FCF Ratio
3.2328.6812.125.454.67-
Net Debt / Equity Ratio
0.130.230.240.310.410.48
Net Debt / EBITDA Ratio
1.042.109.042.3610.243.50
Net Debt / FCF Ratio
1.3120.177.924.393.65-5.21
Asset Turnover
1.010.950.900.920.840.93
Inventory Turnover
3.423.393.143.273.423.43
Quick Ratio
0.741.130.530.540.580.51
Current Ratio
1.192.000.921.010.880.90
Return on Equity (ROE)
7.71%5.97%-10.58%4.97%-2.24%3.34%
Return on Assets (ROA)
3.16%2.55%-0.83%2.38%-0.73%2.70%
Return on Invested Capital (ROIC)
6.35%4.90%-1.97%4.06%-1.67%2.48%
Return on Capital Employed (ROCE)
7.30%4.90%-1.90%5.90%-2.00%6.70%
Earnings Yield
7.15%5.05%-7.02%3.35%-1.38%1.25%
FCF Yield
9.44%1.00%2.11%4.94%6.83%-3.67%
Dividend Yield
0.62%0.60%----
Payout Ratio
8.56%-----
Buyback Yield / Dilution
-0.22%-0.53%0.03%0.03%0.03%0.00%
Total Shareholder Return
0.40%0.07%0.03%0.03%0.03%0.00%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.